The extract of litsea japonica reduced the development of diabetic nephropathy via the inhibition of advanced glycation end products accumulation in db/db mice

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Sohn, Eunjin ^a   Kim, Junghyun ^a   Kim, Chan Sik ^a   Lee, Yun Mi ^a   Jo, Kyuhyung ^a   Shin, So Dam ^a   Kim, Joo Hwan ^b   Kim, Jin Sook ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^b Gachon University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE; HEMOGLOBIN A1C; LITSEA JAPONICA EXTRACT; NEPHRIN; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL LOSS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG MECHANISM; DRUG SCREENING; GLOMERULUS; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LITSEA JAPONICA; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; RENAL PROTECTION; TREATMENT RESPONSE;

EID: 84879395544     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/769416     Document Type: Article

References (40)

1. Vestra M. D., Saller A., Bortoloso E., Mauer M., Fioretto P., Structural involvement in type 1 and type 2 diabetic nephropathy. Diabetes and Metabolism 2000 26 supplement 4 8 14 2-s2.0-0033866260
2. Kalia K., Sharma S., Mistry K., Non-enzymatic glycosylation of immunoglobulins in diabetic nephropathy. Clinica Chimica Acta 2004 347 1-2 169 176 2-s2.0-4143111353 10.1016/j.cccn.2004.04.016
3. Brownlee M., Advanced protein glycosylation in diabetes and aging. Annual Review of Medicine 1995 46 223 234 2-s2.0-0028908348 10.1146/annurev.med.46.1. 223
4. Mauer S. M., Steffes M. W., Ellis E. N., Structural-functional relationships in diabetic nephropathy. The Journal of Clinical Investigation 1984 74 4 1143 1155 2-s2.0-0021715307
5. Chuang P. Y., Yu Q., Fang W., Uribarri J., He J. C., Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor. Kidney International 2007 72 8 965 976 2-s2.0-34948906839 10.1038/sj.ki.5002456
6. Zhang Y., Chen B., Hou X. H., Guan G. J., Liu G., Liu H. Y., Li X. G., Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats. Chinese Medical Journal 2007 120 11 988 995 2-s2.0-34250175849
7. Estacio R. O., Schrier R. W., Diabetic nephropathy: pathogenesis, diagnosis, and prevention of progression. Advances in Internal Medicine 2001 46 359 408 2-s2.0-0035218891
8. Zhang A., Huang S., Progress in pathogenesis of proteinuria. International Journal of Nephrology 2012 2012 14 314251 10.1155/2012/314251
9. Alarcon-Aguilara F. J., Roman-Ramos R., Perez-Gutierrez S., Aguilar-Contreras A., Contreras-Weber C. C., Flores-Saenz J. L., Study of the anti-hyperglycemic effect of plants used as antidiabetics. Journal of Ethnopharmacology 1998 61 2 101 110 2-s2.0-0032102928 10.1016/S0378-8741(98) 00020-8
10. Li W. L., Zheng H. C., Bukuru J., De Kimpe N., Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. Journal of Ethnopharmacology 2004 92 1 1 21 2-s2.0-1942424088 10.1016/j.jep.2003.12.031
11. Kim E., Boo H. J., Hyun J. H., Kim S. C., Kang J. I., Kim M. K., Yoo E. S., Kang H. K., The effects of Litsea japonica on the induction of apoptosis in HL-60/ADR. Korean Journal of Pharmacognosy 2009 40 1 65 69 2-s2.0-76649142075
12. Tanaka H. N. T., Nakamura T., Ichino K., Ito K., Tanaka T., Butanolides from Litsea japonica. Phytochemistry 1990 29 3 857 859 2-s2.0-0000826888
13. Min B. S., Lee S. Y., Kim J. H., Kwon O. K., Park B. Y., An R. B., Lee J. K., Moon H. I., Kim T. J., Kim Y. H., Joung H., Lee H. K., Lactones from the leaves of Litsea japonica and their anti-complement activity. Journal of Natural Products 2003 66 10 1388 1390 2-s2.0-10744228487 10.1021/np030227i
14. Miwa I., Tsugawa T., Koyasu K., Terada Y., Inhibition of advanced protein glycation by 8-quinolinecarboxylic hydrazide. Pharmacology 1996 52 5 314 320 2-s2.0-0029974764
15. Forbes J. M., Soulis T., Thallas V., Panagiotopoulos S., Long D. M., Vasan S., Wagle D., Jerums G., Cooper M. E., Renoprotective effects of a novel inhibitor of advanced glycation. Diabetologia 2001 44 1 108 114 2-s2.0-0035125966 10.1007/s001250051587
16. Mundel P., Reiser J., New aspects of podocyte cell biology. Kidney and Blood Pressure Research 1997 20 3 173 176 2-s2.0-0030798521
17. Toyoda M., Suzuki D., Umezono T., Uehara G., Maruyama M., Honma M., Sakai T., Sakai H., Expression of human nephrin mRNA in diabetic nephropathy. Nephrology Dialysis Transplantation 2004 19 2 380 385 2-s2.0-1042303655 10.1093/ndt/gfg545
18. Like A. A., Lavine R. L., Poffenbarger P. L., Chick W. L., Studies in the diabetic mutant mouse. VI. Evolution of glomerular lesions and associated proteinuria. The American Journal of Pathology 1972 66 2 193 224 2-s2.0-0015291950
19. Ziyadeh F. N., Hoffman B. B., Han D. C., Iglesias-De La Cruz M. C., Hong S. W., Isono M., Chen S., McGowan T. A., Sharma K., Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor- β antibody in db/db diabetic mice. Proceedings of the National Academy of Sciences of the United States of America 2000 97 14 8015 8020 2-s2.0-0034608948 10.1073/pnas.120055097
20. Soler M. J., Riera M., Batlle D., New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathy. Experimental Diabetes Research 2012 2012 19 616313 10.1155/2012/616313
21. Coughlan M. T., Mibus A. L., Forbes J. M., Oxidative stress and advanced glycation in diabetic nephropathy. Annals of the New York Academy of Sciences 2008 1126 190 193 2-s2.0-42549146445 10.1196/annals.1433.018
22. Fukami K., Yamagishi S. I., Ueda S., Okuda S., Role of AGEs in diabetic nephropathy. Current Pharmaceutical Design 2008 14 10 946 952 2-s2.0-44449132702 10.2174/138161208784139710
23. Brownlee M., The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005 54 6 1615 1625 2-s2.0-20044376702 10.2337/diabetes.54. 6.1615
24. Wendt T. M., Tanji N., Guo J., Kislinger T. R., Qu W., Lu Y., Bucciarelli L. G., Ling Rong L., Moser B., Markowitz G. S., Stein G., Bierhaus A., Liliensiek B., Arnold B., Nawroth P. P., Stern D. M., D'Agati V. D., Schmidt A. M., RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. The American Journal of Pathology 2003 162 4 1123 1137 2-s2.0-0037377697
25. Susztak K., Raff A. C., Schiffer M., Böttinger E. P., Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006 55 1 225 233 2-s2.0-33644783770 10.2337/diabetes.55.1.225
26. Mundel P., Heid H. W., Mundel T. M., Krüger M., Reiser J., Kriz W., Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes. Journal of Cell Biology 1997 139 1 193 204 2-s2.0-0030816323 10.1083/jcb.139.1.193
27. Thornalley P. J., Battah S., Ahmed N., Karachalias N., Agalou S., Babaei-Jadidi R., Dawnay A., Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. The Biochemical Journal 2003 375 3 581 592 2-s2.0-0242468729 10.1042/BJ20030763
28. Ahmed N., Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Research and Clinical Practice 2005 67 1 3 21 2-s2.0-11144324314 10.1016/j.diabres.2004.09.004
29. Rahbar S., Figarola J. L., Novel inhibitors of advanced glycation endproducts. Archives of Biochemistry and Biophysics 2003 419 1 63 79 2-s2.0-0142029114 10.1016/j.abb.2003.08.009
30. Peppa M., Brem H., Cai W., Zhang J. G., Basgen J., Li Z., Vlassara H., Uribarri J., Prevention and reversal of diabetic nephropathy in db/db mice treated with alagebrium (ALT-711). American Journal of Nephrology 2006 26 5 430 436 2-s2.0-33845776585 10.1159/000095786
31. Kim Y. S., Kim J., Kim C. S., KIOM-79, an inhibitor of AGEs-protein cross-linking, prevents progression of nephropathy in zucker diabetic fatty rats. Evidence-Based Complementary and Alternative Medicine 2011 2011 10 761859 10.1093/ecam/nep078
32. Babu P. V. A., Sabitha K. E., Shyamaladevi C. S., Effect of green tea extract on advanced glycation and cross-linking of tail tendon collagen in streptozotocin induced diabetic rats. Food and Chemical Toxicology 2008 46 1 280 285 2-s2.0-36849022103 10.1016/j.fct.2007.08.005
33. Matsuda H., Wang T., Managi H., Yoshikawa M., Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorganic and Medicinal Chemistry 2003 11 24 5317 5323 2-s2.0-0344851580 10.1016/j.bmc.2003.09.045
34. Tryggvason K., Patrakka J., Wartiovaara J., Hereditary proteinuria syndromes and mechanisms of proteinuria. The New England Journal of Medicine 2006 354 13 1387 1401 2-s2.0-33645403170 10.1056/NEJMra052131
35. Tryggvason K., Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm. Journal of the American Society of Nephrology 1999 10 11 2440 2445 2-s2.0-0032730875
36. Juhila J., Lassila M., Roozendaal R., Lehtonen E., Messing M., Langer B., Kerjaschki D., Verbeek J. S., Holthofer H., Inducible nephrin transgene expression in podocytes rescues nephrin-deficient mice from perinatal death. The American Journal of Pathology 2010 176 1 51 63 2-s2.0-73949093642 10.2353/ajpath.2010.080843
37. Bailey C. J., Turner R. C., Metformin. The New England Journal of Medicine 1996 334 9 574 579 2-s2.0-0030605388
38. Amador-Licona N., Guízar-Mendoza J. M., Vargas E., Sánchez-Camargo G., Zamora-Mata L., The short-term effect of a switch from glybenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus. Archives of Medical Research 2000 31 6 571 575 2-s2.0-0034464263 10.1016/S0188-4409(00)00241-1
39. Kiho T., Kato M., Usui S., Hirano K., Effect of buformin and metformin on formation of advanced glycation end products by methylglyoxal. Clinica Chimica Acta 2005 358 1-2 139 145 2-s2.0-22044458172 10.1016/j.cccn.2005.02.012
40. Fornoni A., Ijaz A., Tejada T., Lenz O., Role of inflammation in diabetic nephropathy. Current Diabetes Reviews 2008 4 1 10 17 2-s2.0-38949105531 10.2174/157339908783502361